+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intraoperative Neuromonitoring Market By Products and Services, By Source Type, By Application, By Modality, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 251 Pages
  • December 2023
  • Region: Global
  • Allied Market Research
  • ID: 5927288
Description Jump to:
The global intraoperative neuromonitoring market was valued at $4,819.15 million in 2022, and is projected to reach $8,729.3 million by 2032, registering a CAGR of 6.1% from 2023 to 2032. Intraoperative neurophysiologic monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. The use of neuromonitoring offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions are reduced.

The major factor driving the growth of the intraoperative neuromonitoring market is prevalence of chronic diseases, encompassing neurological disorders, cardiovascular conditions, and osteoarthritis. These conditions often require surgical intervention, where intraoperative neuromonitoring emerges as a pivotal tool, enhancing surgical precision and minimizing complications. In addition, the rise in number of surgical procedures further drives the market growth. For instance, in 2022, a White Paper from Etiometry Inc., a digital health company, reported that approximately 900,000 cardiac surgeries are performed annually in the U.S., with an average increase in surgery volume of 5% per year. Further, with an aging population, the prevalence of chronic diseases is expected to soar, leading to a higher frequency of complex surgeries. This demographic shift is anticipated to be a key driver, fostering sustained market growth for intraoperative neuromonitoring as an indispensable component of advanced surgical practices.

Moreover, the presence of favorable reimbursement policies significantly contributes to the robust growth of the intraoperative neuromonitoring market. As healthcare systems acknowledge the importance of these monitoring technologies in ensuring patient safety during surgeries, supportive reimbursement frameworks incentivize healthcare providers to integrate intraoperative neuromonitoring into their practices. Reimbursement policies not only alleviate financial burdens on healthcare facilities but also encourage broader adoption, making these advanced monitoring solutions more accessible. This alignment between the benefits of intraoperative neuromonitoring and favorable reimbursement policies serves as a key catalyst, fostering a conducive environment for sustained market expansion.

The intraoperative neuromonitoring market is segmented on the basis of products & services, source type, application, modality, end user, and region. On the basis of product & service, the market is segmented into system, accessory, and service. As per source type, the market is segmented into insourced monitoring and outsourced monitoring. Depending on application, the market is segmented into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. On the basis of modality, the market is segmented into motor evoked potential (MEPs), somatosensory evoked potential (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEPs), and visual evoked potential (VEPs). According to end user, market is segmented into hospitals and ambulatory surgical centers (ASCs). Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The major key players that operate in the global intraoperative neuromonitoring market are NuVasive, Inc.,Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation, Accurate Monitoring, Computational Diagnostics, Inc., SpecialtyCare, NeuroStyle Pte. Ltd, and Intranerve Neuroscience Holdings, LLC.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intraoperative neuromonitoring market analysis from 2022 to 2032 to identify the prevailing intraoperative neuromonitoring market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intraoperative neuromonitoring market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intraoperative neuromonitoring market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Products and Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • ENT Surgery
  • Vascular Surgery
  • Other surgeries

By Modality

  • Motor evoked potentials (MEPs)
  • Somatosensory evoked potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem auditory evoked potentials (BAEPs)
  • Visual evoked potentials (VEPs)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Medtronic plc
  • inomed Medizintechnik GmbH
  • Nihon Kohden Corporation
  • Accurate Monitoring
  • SpecialtyCare
  • NeuroStyle Pte.Ltd
  • Intranerve Neuroscience Holdings, LLC
  • Natus Medical Incorporated.
  • Computational Diagnostics, Inc.
  • NuVasive, Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic diseases
3.4.1.2. Rise in geriatric population
3.4.1.3. Applications of IONM in various surgeries
3.4.2. Restraints
3.4.2.1. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Insourced Monitoring
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Outsourced Monitoring
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Spinal Surgery
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurosurgery
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Orthopedic Surgery
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. ENT Surgery
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Vascular Surgery
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Other surgeries
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Motor evoked potentials (MEPs)
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Somatosensory evoked potentials (SSEPs)
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Electroencephalography (EEG)
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Electromyography (EMG)
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
7.6. Brainstem auditory evoked potentials (BAEPs)
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by region
7.6.3. Market share analysis by country
7.7. Visual evoked potentials (VEPs)
7.7.1. Key market trends, growth factors and opportunities
7.7.2. Market size and forecast, by region
7.7.3. Market share analysis by country
CHAPTER 8: INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospitals
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Ambulatory Surgical Centers (ASCs)
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
CHAPTER 9: INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Products and Services
9.2.3. Market size and forecast, by Source Type
9.2.4. Market size and forecast, by Application
9.2.5. Market size and forecast, by Modality
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Products and Services
9.2.7.1.2. Market size and forecast, by Source Type
9.2.7.1.3. Market size and forecast, by Application
9.2.7.1.4. Market size and forecast, by Modality
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Products and Services
9.2.7.2.2. Market size and forecast, by Source Type
9.2.7.2.3. Market size and forecast, by Application
9.2.7.2.4. Market size and forecast, by Modality
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Products and Services
9.2.7.3.2. Market size and forecast, by Source Type
9.2.7.3.3. Market size and forecast, by Application
9.2.7.3.4. Market size and forecast, by Modality
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Products and Services
9.3.3. Market size and forecast, by Source Type
9.3.4. Market size and forecast, by Application
9.3.5. Market size and forecast, by Modality
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Products and Services
9.3.7.1.2. Market size and forecast, by Source Type
9.3.7.1.3. Market size and forecast, by Application
9.3.7.1.4. Market size and forecast, by Modality
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Products and Services
9.3.7.2.2. Market size and forecast, by Source Type
9.3.7.2.3. Market size and forecast, by Application
9.3.7.2.4. Market size and forecast, by Modality
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Products and Services
9.3.7.3.2. Market size and forecast, by Source Type
9.3.7.3.3. Market size and forecast, by Application
9.3.7.3.4. Market size and forecast, by Modality
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Products and Services
9.3.7.4.2. Market size and forecast, by Source Type
9.3.7.4.3. Market size and forecast, by Application
9.3.7.4.4. Market size and forecast, by Modality
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Products and Services
9.3.7.5.2. Market size and forecast, by Source Type
9.3.7.5.3. Market size and forecast, by Application
9.3.7.5.4. Market size and forecast, by Modality
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Products and Services
9.3.7.6.2. Market size and forecast, by Source Type
9.3.7.6.3. Market size and forecast, by Application
9.3.7.6.4. Market size and forecast, by Modality
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Products and Services
9.4.3. Market size and forecast, by Source Type
9.4.4. Market size and forecast, by Application
9.4.5. Market size and forecast, by Modality
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Products and Services
9.4.7.1.2. Market size and forecast, by Source Type
9.4.7.1.3. Market size and forecast, by Application
9.4.7.1.4. Market size and forecast, by Modality
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Products and Services
9.4.7.2.2. Market size and forecast, by Source Type
9.4.7.2.3. Market size and forecast, by Application
9.4.7.2.4. Market size and forecast, by Modality
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Products and Services
9.4.7.3.2. Market size and forecast, by Source Type
9.4.7.3.3. Market size and forecast, by Application
9.4.7.3.4. Market size and forecast, by Modality
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Products and Services
9.4.7.4.2. Market size and forecast, by Source Type
9.4.7.4.3. Market size and forecast, by Application
9.4.7.4.4. Market size and forecast, by Modality
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Products and Services
9.4.7.5.2. Market size and forecast, by Source Type
9.4.7.5.3. Market size and forecast, by Application
9.4.7.5.4. Market size and forecast, by Modality
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Products and Services
9.4.7.6.2. Market size and forecast, by Source Type
9.4.7.6.3. Market size and forecast, by Application
9.4.7.6.4. Market size and forecast, by Modality
9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Products and Services
9.5.3. Market size and forecast, by Source Type
9.5.4. Market size and forecast, by Application
9.5.5. Market size and forecast, by Modality
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Products and Services
9.5.7.1.2. Market size and forecast, by Source Type
9.5.7.1.3. Market size and forecast, by Application
9.5.7.1.4. Market size and forecast, by Modality
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Products and Services
9.5.7.2.2. Market size and forecast, by Source Type
9.5.7.2.3. Market size and forecast, by Application
9.5.7.2.4. Market size and forecast, by Modality
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Products and Services
9.5.7.3.2. Market size and forecast, by Source Type
9.5.7.3.3. Market size and forecast, by Application
9.5.7.3.4. Market size and forecast, by Modality
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Products and Services
9.5.7.4.2. Market size and forecast, by Source Type
9.5.7.4.3. Market size and forecast, by Application
9.5.7.4.4. Market size and forecast, by Modality
9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. NuVasive, Inc.
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Medtronic plc
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.2.7. Key strategic moves and developments
11.3. Computational Diagnostics, Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.4. Natus Medical Incorporated.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.5. Accurate Monitoring
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.6. inomed Medizintechnik GmbH
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Nihon Kohden Corporation
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. SpecialtyCare
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.9. Intranerve Neuroscience Holdings, LLC
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Key strategic moves and developments
11.10. NeuroStyle Pte.Ltd
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
List of Tables
Table 01. Global Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 02. Intraoperative Neuromonitoring Market for Systems, by Region, 2022-2032 ($Million)
Table 03. Intraoperative Neuromonitoring Market for Accessories, by Region, 2022-2032 ($Million)
Table 04. Intraoperative Neuromonitoring Market for Services, by Region, 2022-2032 ($Million)
Table 05. Global Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 06. Intraoperative Neuromonitoring Market for Insourced Monitoring, by Region, 2022-2032 ($Million)
Table 07. Intraoperative Neuromonitoring Market for Outsourced Monitoring, by Region, 2022-2032 ($Million)
Table 08. Global Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 09. Intraoperative Neuromonitoring Market for Spinal Surgery, by Region, 2022-2032 ($Million)
Table 10. Intraoperative Neuromonitoring Market for Neurosurgery, by Region, 2022-2032 ($Million)
Table 11. Intraoperative Neuromonitoring Market for Orthopedic Surgery, by Region, 2022-2032 ($Million)
Table 12. Intraoperative Neuromonitoring Market for Ent Surgery, by Region, 2022-2032 ($Million)
Table 13. Intraoperative Neuromonitoring Market for Vascular Surgery, by Region, 2022-2032 ($Million)
Table 14. Intraoperative Neuromonitoring Market for Other Surgeries, by Region, 2022-2032 ($Million)
Table 15. Global Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 16. Intraoperative Neuromonitoring Market for Motor Evoked Potentials (Meps), by Region, 2022-2032 ($Million)
Table 17. Intraoperative Neuromonitoring Market for Somatosensory Evoked Potentials (Sseps), by Region, 2022-2032 ($Million)
Table 18. Intraoperative Neuromonitoring Market for Electroencephalography (EEG), by Region, 2022-2032 ($Million)
Table 19. Intraoperative Neuromonitoring Market for Electromyography (Emg), by Region, 2022-2032 ($Million)
Table 20. Intraoperative Neuromonitoring Market for Brainstem Auditory Evoked Potentials (Baeps), by Region, 2022-2032 ($Million)
Table 21. Intraoperative Neuromonitoring Market for Visual Evoked Potentials (Veps), by Region, 2022-2032 ($Million)
Table 22. Global Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 23. Intraoperative Neuromonitoring Market for Hospitals, by Region, 2022-2032 ($Million)
Table 24. Intraoperative Neuromonitoring Market for Ambulatory Surgical Centers (Ascs), by Region, 2022-2032 ($Million)
Table 25. Intraoperative Neuromonitoring Market, by Region, 2022-2032 ($Million)
Table 26. North America Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 27. North America Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 28. North America Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 29. North America Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 30. North America Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 31. North America Intraoperative Neuromonitoring Market, by Country, 2022-2032 ($Million)
Table 32. U.S. Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 33. U.S. Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 34. U.S. Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 35. U.S. Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 36. U.S. Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 37. Canada Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 38. Canada Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 39. Canada Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 40. Canada Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 41. Canada Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 42. Mexico Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 43. Mexico Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 44. Mexico Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 45. Mexico Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 46. Mexico Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 47. Europe Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 48. Europe Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 49. Europe Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 50. Europe Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 51. Europe Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 52. Europe Intraoperative Neuromonitoring Market, by Country, 2022-2032 ($Million)
Table 53. Germany Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 54. Germany Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 55. Germany Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 56. Germany Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 57. Germany Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 58. France Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 59. France Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 60. France Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 61. France Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 62. France Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 63. UK Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 64. UK Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 65. UK Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 66. UK Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 67. UK Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 68. Italy Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 69. Italy Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 70. Italy Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 71. Italy Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 72. Italy Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 73. Spain Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 74. Spain Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 75. Spain Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 76. Spain Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 77. Spain Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 78. Rest of Europe Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 79. Rest of Europe Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 80. Rest of Europe Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 81. Rest of Europe Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 82. Rest of Europe Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 83. Asia-Pacific Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 84. Asia-Pacific Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 85. Asia-Pacific Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 86. Asia-Pacific Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 87. Asia-Pacific Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 88. Asia-Pacific Intraoperative Neuromonitoring Market, by Country, 2022-2032 ($Million)
Table 89. Japan Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 90. Japan Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 91. Japan Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 92. Japan Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 93. Japan Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 94. China Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 95. China Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 96. China Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 97. China Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 98. China Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 99. India Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 100. India Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 101. India Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 102. India Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 103. India Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 104. Australia Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 105. Australia Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 106. Australia Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 107. Australia Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 108. Australia Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 109. South Korea Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 110. South Korea Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 111. South Korea Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 112. South Korea Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 113. South Korea Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 114. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 115. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 116. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 117. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 118. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 119. LAMEA Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 120. LAMEA Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 121. LAMEA Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 122. LAMEA Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 123. LAMEA Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 124. LAMEA Intraoperative Neuromonitoring Market, by Country, 2022-2032 ($Million)
Table 125. Brazil Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 126. Brazil Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 127. Brazil Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 128. Brazil Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 129. Brazil Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 130. Saudi Arabia Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 131. Saudi Arabia Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 132. Saudi Arabia Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 133. Saudi Arabia Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 134. Saudi Arabia Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 135. South Africa Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 136. South Africa Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 137. South Africa Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 138. South Africa Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 139. South Africa Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 140. Rest of LAMEA Intraoperative Neuromonitoring Market, by Products and Services, 2022-2032 ($Million)
Table 141. Rest of LAMEA Intraoperative Neuromonitoring Market, by Source Type, 2022-2032 ($Million)
Table 142. Rest of LAMEA Intraoperative Neuromonitoring Market, by Application, 2022-2032 ($Million)
Table 143. Rest of LAMEA Intraoperative Neuromonitoring Market, by Modality, 2022-2032 ($Million)
Table 144. Rest of LAMEA Intraoperative Neuromonitoring Market, by End-user, 2022-2032 ($Million)
Table 145. Nuvasive, Inc.: Key Executives
Table 146. Nuvasive, Inc.: Company Snapshot
Table 147. Nuvasive, Inc.: Product Segments
Table 148. Nuvasive, Inc.: Product Portfolio
Table 149. Medtronic PLC: Key Executives
Table 150. Medtronic PLC: Company Snapshot
Table 151. Medtronic PLC: Product Segments
Table 152. Medtronic PLC: Product Portfolio
Table 153. Medtronic PLC: Key Strategies
Table 154. Computational Diagnostics, Inc.: Key Executives
Table 155. Computational Diagnostics, Inc.: Company Snapshot
Table 156. Computational Diagnostics, Inc.: Service Segments
Table 157. Computational Diagnostics, Inc.: Product Portfolio
Table 158. Natus Medical Incorporated.: Key Executives
Table 159. Natus Medical Incorporated.: Company Snapshot
Table 160. Natus Medical Incorporated.: Product Segments
Table 161. Natus Medical Incorporated.: Product Portfolio
Table 162. Accurate Monitoring: Key Executives
Table 163. Accurate Monitoring: Company Snapshot
Table 164. Accurate Monitoring: Product Segments
Table 165. Accurate Monitoring: Service Segments
Table 166. Accurate Monitoring: Product Portfolio
Table 167. Inomed Medizintechnik GmbH: Key Executives
Table 168. Inomed Medizintechnik GmbH: Company Snapshot
Table 169. Inomed Medizintechnik GmbH: Product Segments
Table 170. Inomed Medizintechnik GmbH: Service Segments
Table 171. Inomed Medizintechnik GmbH: Product Portfolio
Table 172. Nihon Kohden Corporation: Key Executives
Table 173. Nihon Kohden Corporation: Company Snapshot
Table 174. Nihon Kohden Corporation: Product Segments
Table 175. Nihon Kohden Corporation: Product Portfolio
Table 176. Specialtycare: Key Executives
Table 177. Specialtycare: Company Snapshot
Table 178. Specialtycare: Service Segments
Table 179. Specialtycare: Product Portfolio
Table 180. Intranerve Neuroscience Holdings, LLC: Key Executives
Table 181. Intranerve Neuroscience Holdings, LLC: Company Snapshot
Table 182. Intranerve Neuroscience Holdings, LLC: Service Segments
Table 183. Intranerve Neuroscience Holdings, LLC: Product Portfolio
Table 184. Intranerve Neuroscience Holdings, LLC: Key Strategies
Table 185. Neurostyle Pte.Ltd.: Key Executives
Table 186. Neurostyle Pte.Ltd.: Company Snapshot
Table 187. Neurostyle Pte.Ltd.: Product Segments
Table 188. Neurostyle Pte.Ltd.: Product Portfolio
List of Figures
Figure 01. Intraoperative Neuromonitoring Market, 2022-2032
Figure 02. Segmentation of Intraoperative Neuromonitoring Market,2022-2032
Figure 03. Top Impacting Factors in Intraoperative Neuromonitoring Market (2022 to 2032)
Figure 04. Top Investment Pockets in Intraoperative Neuromonitoring Market (2023-2032)
Figure 05. Low Bargaining Power of Suppliers
Figure 06. Low Threat of New Entrants
Figure 07. Low Threat of Substitutes
Figure 08. Low Intensity of Rivalry
Figure 09. Low Bargaining Power of Buyers
Figure 10. Global Intraoperative Neuromonitoring Market:Drivers, Restraints and Opportunities
Figure 11. Intraoperative Neuromonitoring Market, by Products and Services, 2022 and 2032(%)
Figure 12. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Systems, by Country 2022 and 2032(%)
Figure 13. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Accessories, by Country 2022 and 2032(%)
Figure 14. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Services, by Country 2022 and 2032(%)
Figure 15. Intraoperative Neuromonitoring Market, by Source Type, 2022 and 2032(%)
Figure 16. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Insourced Monitoring, by Country 2022 and 2032(%)
Figure 17. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Outsourced Monitoring, by Country 2022 and 2032(%)
Figure 18. Intraoperative Neuromonitoring Market, by Application, 2022 and 2032(%)
Figure 19. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Spinal Surgery, by Country 2022 and 2032(%)
Figure 20. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Neurosurgery, by Country 2022 and 2032(%)
Figure 21. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Orthopedic Surgery, by Country 2022 and 2032(%)
Figure 22. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Ent Surgery, by Country 2022 and 2032(%)
Figure 23. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Vascular Surgery, by Country 2022 and 2032(%)
Figure 24. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Other Surgeries, by Country 2022 and 2032(%)
Figure 25. Intraoperative Neuromonitoring Market, by Modality, 2022 and 2032(%)
Figure 26. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Motor Evoked Potentials (Meps), by Country 2022 and 2032(%)
Figure 27. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Somatosensory Evoked Potentials (Sseps), by Country 2022 and 2032(%)
Figure 28. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Electroencephalography (EEG), by Country 2022 and 2032(%)
Figure 29. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Electromyography (Emg), by Country 2022 and 2032(%)
Figure 30. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Brainstem Auditory Evoked Potentials (Baeps), by Country 2022 and 2032(%)
Figure 31. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Visual Evoked Potentials (Veps), by Country 2022 and 2032(%)
Figure 32. Intraoperative Neuromonitoring Market, by End-user, 2022 and 2032(%)
Figure 33. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Hospitals, by Country 2022 and 2032(%)
Figure 34. Comparative Share Analysis of Intraoperative Neuromonitoring Market for Ambulatory Surgical Centers (Ascs), by Country 2022 and 2032(%)
Figure 35. Intraoperative Neuromonitoring Market by Region, 2022 and 2032(%)
Figure 36. U.S. Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 37. Canada Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 38. Mexico Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 39. Germany Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 40. France Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 41. UK Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 42. Italy Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 43. Spain Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 44. Rest of Europe Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 45. Japan Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 46. China Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 47. India Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 48. Australia Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 49. South Korea Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 50. Rest of Asia-Pacific Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 51. Brazil Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 52. Saudi Arabia Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 53. South Africa Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 54. Rest of LAMEA Intraoperative Neuromonitoring Market, 2022-2032 ($Million)
Figure 55. Top Winning Strategies, by Year (2020-2023)
Figure 56. Top Winning Strategies, by Development (2020-2023)
Figure 57. Top Winning Strategies, by Company (2020-2023)
Figure 58. Product Mapping of Top 10 Players
Figure 59. Competitive Dashboard
Figure 60. Competitive Heatmap: Intraoperative Neuromonitoring Market
Figure 61. Top Player Positioning, 2022
Figure 62. Nuvasive, Inc.: Net Sales, 2020-2022 ($Million)
Figure 63. Nuvasive, Inc.: Revenue Share by Segment, 2022 (%)
Figure 64. Nuvasive, Inc.: Revenue Share by Region, 2022 (%)
Figure 65. Medtronic PLC: Net Sales, 2021-2023 ($Million)
Figure 66. Medtronic PLC: Revenue Share by Segment, 2023 (%)
Figure 67. Medtronic PLC: Revenue Share by Region, 2023 (%)
Figure 68. Natus Medical Incorporated: Net Revenue, 2019-2021 ($Million)
Figure 69. Natus Medical Incorporated: Revenue Share by Segment, 2021 (%)
Figure 70. Natus Medical Incorporated: Revenue Share by Region, 2021 (%)
Figure 71. Nihon Kohden Corporation: Net Sales, 2020-2022 ($Million)
Figure 72. Nihon Kohden Corporation: Revenue Share by Segment, 2022 (%)
Figure 73. Nihon Kohden Corporation: Revenue Share by Region, 2022 (%)

Companies Mentioned

  • Medtronic plc
  • inomed Medizintechnik GmbH
  • Nihon Kohden Corporation
  • Accurate Monitoring
  • SpecialtyCare
  • NeuroStyle Pte.Ltd
  • Intranerve Neuroscience Holdings, LLC
  • Natus Medical Incorporated.
  • Computational Diagnostics, Inc.
  • NuVasive, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages251
PublishedDecember 2023
Forecast Period2022 - 2032
Estimated Market Value ( USD ) in 2022 $ 4819.15 million
Forecasted Market Value ( USD ) by 2032 $ 8729.3 million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Intraoperative Neuromonitoring Market Report and Forecast 2024-2032 - Product Image

Intraoperative Neuromonitoring Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Intraoperative Neuromonitoring Market by Type, Modality, Application - Global Forecast 2025-2030 - Product Image

Intraoperative Neuromonitoring Market by Type, Modality, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Source Type (Insourced Monitoring, and Outsourced Monitoring), By End User, By Products & Services, By Application, By Modality, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Source Type (Insourced Monitoring, and Outsourced Monitoring), By End User, By Products & Services, By Application, By Modality, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Intraoperative Neuromonitoring Market Report by Product and Services, Source Type, Application, End User, and Region 2024-2032 - Product Image

Intraoperative Neuromonitoring Market Report by Product and Services, Source Type, Application, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Intraoperative Neuromonitoring Global Market Report 2024 - Product Image

Intraoperative Neuromonitoring Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.